<DOC>
	<DOCNO>NCT00991120</DOCNO>
	<brief_summary>The purpose Extension Phase COMPASS-HF study continue observe safety Chronicle® Implantable Hemodynamic Monitor ( IHM ) system Chronicle ICD system provide study doctor continue access heart pressure information record Chronicle device may use help manage heart failure . The Extension Phase COMPASS-HF study limit people already receive investigational system currently enrol Chronicle IHM ICD study .</brief_summary>
	<brief_title>Extension Phase Chronicle® Offers Management Patients With Advanced Signs &amp; Symptoms Heart Failure Study</brief_title>
	<detailed_description>For purpose Extension Phase , Chronicle IHM ICD system continue use patient moderate severe heart failure intend monitor hemodynamic information , include right ventricular pulmonary artery pressure , heart rate activity . The COMPASS-HF Extension Phase include follow Chronicle IHM study : - The Chronicle IHM Phase I/II study , 148 patient technology assessment study begin enrol patient 1998 complete endpoint driven follow period 3 month safety 12 month efficacy 2002 - The Chronicle Offers Management Patients Advanced Signs &amp; Symptoms Heart Failure ( COMPASS-HF ) study , 274 patient randomize study begin enrol patient 2003 complete endpoint driven follow period 6 month 2005 - The Pulmonary Arterial Hypertension Pilot ( PAH Pilot ) study , 24 patient pilot study begin enrol patient 2003 complete endpoint driven follow period 12 week 2006 - The Reducing Decompensation Events Utilizing intraCardiac Pressures Patients Chronic HF ( REDUCEhf ) study , 400 patient randomize study begin enrol patient 2006 complete endpoint driven follow period 12 month 2010 . In four study , patient implant Chronicle IHM ICD system upon completion endpoint drive follow period , enter long term follow continue see every six month study visit . As Chronicle IHM ICD system receive U.S. Food Drug Administration approval , COMPASS-HF Extension Phase initiate mean allow continued access Chronicle IHM data study investigator one concurrently enrol study follow schedule . No additional study objectives new enrollment capture COMPASS-HF Extension Phase .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Patient provide write informed consent Extension Phase Patient implant Chronicle IHM ICD device actively enrol one follow study : COMPASSHF , Chronicle IHM Phase I/II , REDUCEhf PAH Pilot Study Patient unwilling transmit Chronicle IHM ICD device data direct study clinician unwilling participate protocol schedule follow visit ( every six month )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>